Planning for Mpox on a College Campus: A Model-Based Decision-Support Tool

被引:6
作者
Savinkina, Alexandra [1 ,2 ,4 ]
Chitwood, Melanie [1 ,2 ]
Kwon, Jiye [1 ,2 ]
Pitzer, Virginia E. E. [1 ,2 ]
Gonsalves, Gregg [1 ,2 ]
Paltiel, A. David [2 ,3 ]
机构
[1] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA
[2] Yale Sch Publ Hlth, Publ Hlth Modeling Unit, New Haven, CT USA
[3] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA
[4] Yale Sch Publ Hlth, 60 Coll St, New Haven, CT 06511 USA
关键词
MONKEYPOX VIRUS; TRANSMISSION; INFECTION;
D O I
10.7326/M22-2734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In spring and summer 2022, an outbreak of mpox occurred worldwide, largely confined to men who have sex with men (MSM). There was concern that mpox could break swiftly into congregate settings and populations with high levels of regular frequent physical contact, like university campus communities. Objective: To estimate the likelihood of an mpox outbreak and the potential effect of mitigation measures in a residential college setting. Design: A stochastic dynamic SEIR (susceptible, exposed but not infectious, infectious, or recovered) model of mpox transmission in a study population was developed, composed of: a high-risk group representative of the population of MSM with a basic reproductive number (R-0) of 2.4 and a low-risk group with an R0 of 0.8. Base input assumptions included an incubation time of 7.6 days and time to recovery of 21 days. Setting: U.S. residential college campus. Participants: Hypothetical cohort of 6500 students. Intervention: Isolation, quarantine, and vaccination of close contacts. Measurements: Proportion of 1000 simulations producing sustained transmission; mean cases given sustained transmission; maximum students isolated, quarantined, and vaccinated. All projections are estimated over a planning horizon of 100 days. Results: Without mitigation measures, the model estimated an 83% likelihood of sustained transmission, leading to an average of 183 cases. With detection and isolation of 20%, 50%, and 80% of cases, the average infections would fall to 117, 37, and 8, respectively. Reactive vaccination of contacts of detected cases (assuming 50% detection and isolation) reduced mean cases from 37 to 17, assuming 20 vaccinated contacts per detected case. Preemptive vaccination of 50% of the high-risk population before outbreak reduced cases from 37 to 14, assuming 50% detection and isolation. Limitation: A model is a stylized portrayal of behavior and transmission on a university campus. Conclusion: Based on our current understanding of mpox epidemiology among MSM in the United States, this model based analysis suggests that future outbreaks of mpox on college campuses may be controlled with timely detection and isolation of symptomatic cases.
引用
收藏
页码:340 / 347
页数:8
相关论文
共 36 条
  • [1] Clinical features and management of human monkeypox: a retrospective observational study in the UK
    Adler, Hugh
    Gould, Susan
    Hine, Paul
    Snell, Luke B.
    Wong, Waison
    Houlihan, Catherine F.
    Osborne, Jane C.
    Rampling, Tommy
    Beadsworth, Mike Bj
    Duncan, Christopher Ja
    Dunning, Jake
    Fletcher, Tom E.
    Hunter, Ewan R.
    Jacobs, Michael
    Khoo, Saye H.
    Newsholme, William
    Porter, David
    Porter, Robert J.
    Ratcliffe, Libuse
    Schmid, Matthias L.
    Semple, Malcolm G.
    Tunbridge, Anne J.
    Wingfield, Tom
    Price, Nicholas M.
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (08) : 1153 - 1162
  • [2] BRANDA F, 2023, J MED VIROL, V95
  • [3] Centers for Disease Control and Prevention, 2022, MPOX OUTBR GLOB MAP
  • [4] Centers for Disease Control and Prevention, 2022, Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. Mpox Outbreak
  • [5] Centers for Disease Control and Prevention, 2022, CLIN REC
  • [6] Centers for Disease Control and Prevention, 2022, MPOX TOOLK I HIGH ED
  • [7] Centers for Disease Control and Prevention, 2022, INC PREV COST SEX TR
  • [8] Chitwood MH, PREPRINT, DOI 10.1101/2022.08.01.22278199
  • [9] Dreher A, 2022, AXIOS
  • [10] DU ZW, 2022, J TRAVEL MED, V29